| For: | Yan JN, Guo LH, Zhu DP, Ye GL, Shao YF, Zhou HX. Clinical significance and potential application of cuproptosis-related genes in gastric cancer. World J Gastrointest Oncol 2023; 15(7): 1200-1214 [PMID: 37546553 DOI: 10.4251/wjgo.v15.i7.1200] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i7/1200.htm |
| Number | Citing Articles |
| 1 |
Qianqian Jiang, Fei Tong, Yun Xu, Cheng Liu, Qiaoping Xu. Cuproptosis: a promising new target for breast cancer therapy. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03572-2
|
| 2 |
Ling Lu, Wenhui Yang, Yuning Gu, Longtao Jin, Zhaofeng Liang. The role of cuproptosis in the occurrence and development of gastric cancer. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1664200
|
| 3 |
Jiawei Fu, Yijing Ren, Yuping Feng, Tingting Tan, Jia Yang, Xingyue Wang. Ferroptosis and cuproptosis in gastric cancer: Mechanisms, roles, and potential Interplay. The International Journal of Biochemistry & Cell Biology 2026; doi: 10.1016/j.biocel.2026.106942
|
| 4 |
Aichen Liu, Lulu Zhang, Peiqi Yu, Tingzun Nie, Xiaobin Cao, Jing Li, Wenke Sun, Yihao Liang, Songyun Ouyang, Liping Dai, Jingjing Liu. An autoantibody signature targeting cuproptosis-related proteins for non-small cell lung cancer detection and prognosis. PeerJ 2026; 14 doi: 10.7717/peerj.21260
|
| 5 |
Yixian Li, Wenhao Sun, Shaolin Yuan, Xinxin Liu, Ziqi Zhang, Renjun Gu, Pengfei Li, Xin Gu. The role of cuproptosis in gastric cancer. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1435651
|
| 6 |
Anqi Feng, Lingnan He, Zhaoxing Li, Zeyu Wang, Mingchuang Sun, Ziying Zhao, Zehua Zhang, Kang Fang, Hao Wu, Xiaoyuan Wang, Shihan Zhang, Zhukai Chen, Li Zhang, Tao Chen, Meidong Xu. TRIM21 promotes K63-linked ubiquitination of ALKBH5 and suppresses cuproptosis via down-regulation of LIAS in esophageal squamous cell carcinoma. Communications Biology 2025; 8(1) doi: 10.1038/s42003-025-09201-6
|
| 7 |
Luoling Wang, Weilin Chen. Targeting the cuproptosis regulator FDX1 for cancer therapy. Genome Instability & Disease 2026; 7(2) doi: 10.1007/s42764-026-00178-y
|
| 8 |
Annan Wu, Kai Tu, Guangfeng Xia. The emerging role of ferredoxin 1 in cancer: Insights into cuproptosis and therapeutic innovation. International Journal of Biological Macromolecules 2025; 330 doi: 10.1016/j.ijbiomac.2025.147996
|
| 9 |
Zhe Tang, Peichao Guo, Yuanhua Liu. LIAS Promotes Cuproptosis in Prostate Cancer Cells by Suppressing Glycolysis via the p53 Signaling Pathway. The Prostate 2026; 86(1) doi: 10.1002/pros.70049
|
| 10 |
Zhiqin Zhang, Shenhua Shao, Hao Luo, Wangwei Sun, Jianjun Wang, Hongqin Yin. The functions of cuproptosis in gastric cancer: therapy, diagnosis, prognosis. Biomedicine & Pharmacotherapy 2024; 177 doi: 10.1016/j.biopha.2024.117100
|
| 11 |
Ziyi Feng, Ting Liu, Peng Gao, Yongwei Jiang, Meimei Zhao, Yi Liu, Haoyan Zhu, Mo Li, Nan Li, Xiaomu Kong, Liang Ma, Zhipeng Tao. The Association of Lipoic Acid Synthase (LIAS) Gene Methylation With Diabetic Kidney Disease. Journal of Diabetes Research 2025; 2025(1) doi: 10.1155/jdr/4342250
|